全文获取类型
收费全文 | 263267篇 |
免费 | 24563篇 |
国内免费 | 20567篇 |
专业分类
耳鼻咽喉 | 2011篇 |
儿科学 | 2309篇 |
妇产科学 | 3007篇 |
基础医学 | 32563篇 |
口腔科学 | 4269篇 |
临床医学 | 37864篇 |
内科学 | 38492篇 |
皮肤病学 | 2400篇 |
神经病学 | 14873篇 |
特种医学 | 9550篇 |
外国民族医学 | 198篇 |
外科学 | 25078篇 |
综合类 | 44043篇 |
现状与发展 | 74篇 |
一般理论 | 27篇 |
预防医学 | 15848篇 |
眼科学 | 8169篇 |
药学 | 28174篇 |
299篇 | |
中国医学 | 15566篇 |
肿瘤学 | 23583篇 |
出版年
2024年 | 932篇 |
2023年 | 4373篇 |
2022年 | 11322篇 |
2021年 | 14003篇 |
2020年 | 10639篇 |
2019年 | 9229篇 |
2018年 | 9668篇 |
2017年 | 8510篇 |
2016年 | 8093篇 |
2015年 | 12176篇 |
2014年 | 14953篇 |
2013年 | 12522篇 |
2012年 | 18719篇 |
2011年 | 21531篇 |
2010年 | 13029篇 |
2009年 | 10062篇 |
2008年 | 13337篇 |
2007年 | 13364篇 |
2006年 | 13593篇 |
2005年 | 13850篇 |
2004年 | 8199篇 |
2003年 | 7606篇 |
2002年 | 6374篇 |
2001年 | 5697篇 |
2000年 | 6424篇 |
1999年 | 7178篇 |
1998年 | 4742篇 |
1997年 | 4762篇 |
1996年 | 3680篇 |
1995年 | 3514篇 |
1994年 | 2899篇 |
1993年 | 1969篇 |
1992年 | 2216篇 |
1991年 | 1842篇 |
1990年 | 1569篇 |
1989年 | 1335篇 |
1988年 | 1139篇 |
1987年 | 995篇 |
1986年 | 748篇 |
1985年 | 611篇 |
1984年 | 350篇 |
1983年 | 215篇 |
1982年 | 115篇 |
1981年 | 127篇 |
1980年 | 82篇 |
1979年 | 90篇 |
1978年 | 2篇 |
1975年 | 5篇 |
1974年 | 2篇 |
1941年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
目的了解护理人员的科研能力与职业认同现状及其相关性,为采取针对性措施提高护理人员科研能力,增强其职业认同感提供参考。方法采用护理人员科研能力自评量表与护士职业认同评价量表,对350名护理人员进行调查。结果护理人员科研能力及科研实践能力、专业与发现问题能力、沟通协作能力3个维度得分率分别为37.50%、25.00%、50.00%、50.00%,职业认同评价量表总均分为5.52分。护理科研能力与职业认同呈正相关(P0.01)。结论护理人员具有较高的职业认同,其科研能力尚待加强,科研能力与职业认同呈正相关。管理者应注重护理人员科研能力的培养,从而提高其职业认同。 相似文献
92.
93.
94.
95.
Fuying Chen Linting Huang Changcan Li Jia Zhang Weiqin Yang Beibei Zhang Huaguo Li Dan Deng Jianying Liang Jinwen Shen Zhirong Yao Ming Li 《Clinical genetics》2020,98(2):179-184
Epidermolysis bullosa (EB) is a heritable blistering disorder. We performed a next-generation sequencing-based multigene panel test and successfully predicted 100% of the EB types, including, 36 EB simplex (EBS), 13 junctional EB (JEB), 86 dystrophic EB (DEB), and 3 Kindler EB. Chinese JEB and recessive DEB (RDEB) patients have relatively mild phenotypes; for severe type separately accounts for 45.5% and 23.8%, respectively. We identified 96 novel and 49 recurrent pathogenic variants in 11 genes, although we failed to detect the second mutation in one JEB and five RDEB patients. We identified one novel p.E475K mosaic mutation in the clinically normal mother of one out of 13 EBS patients with KRT5 mutations, one recurrent p.G2034R mosaic mutation, and one novel p.G2043R mosaic mutation in the clinically normal relatives of two out of 19 dominant DEB patients. This study shows that next-generation technology could be an effective tool in diagnosing EB. 相似文献
96.
目的了解上海市黄浦区社会办医疗美容机构的管理人员和医师对《医疗美容管理办法》相关内容的掌握情况,发现存在的问题并提出改善建议.方法采用现场调查与现场问卷调查相结合的方式,对在上海市黄浦区开展医疗美容科目的所有社会办医疗机构(共计38家)进行全覆盖现场调查,并对其中的管理人员41人、相关医师31人进行问卷调查.结果38家社会办医疗美容机构中,美容外科和美容皮肤科的开展率较高,分别为96.8%和97.2%,而美容牙科开展率为52.4%,美容中医科开展率最低(25.0%).管理人员关于非主诊医师可在主诊医师指导下工作的知晓率仅68.3%.关于美容外科、皮肤科、中医科、牙科主诊医师应具备的工作年限,管理人员答对率为90.2%,医师答对率为72.0%,二者有显著性差异(P<0.05).结论社会办医疗美容机构中的二级科目设置需进一步优化,以减少资源空置.应加强对医疗机构管理人员和医师的法律培训,改变经营模式,制定明确的准入与退出机制,从而减少违法违规行为的发生. 相似文献
97.
98.
99.
Sequential Therapy Based on Evolvement of Patterns: A New Model for Treatment of Alzheimer’s Disease
In order to solve the problem of long-term (>9 months) efficacy in the treatment of Alzheimer''s disease (AD) by conventional therapy (CT), a staged and multiply-targeted sequential therapy based on the evolvement of patterns (STEP) was developed. Its main innovations include: (1) the time order of evolution of patterns defined by Chinese medicine (CM) in AD was found, that is, "the orderly pattern evolution starting from Shen (Kidney) deficiency, progressing to phlegm, stasis and fire, and worsening to severe toxin as well as functional collapse"; (2) the cascade hypothesis of Shen deficiency in AD and its sequential therapy based on Shen-reinforcing was proposed, that is, "reinforcing Shen in the early stage and throughout the whole process, resolving phlegm, activating blood and purging fire in the middle stage, detoxifying and replenishing vitality to stop the collapse in the advanced stage", and through meta-analysis, clinical drug use was optimized, thus the leap from "inferential selection" to "evidence-based selection" was realized; (3) the STEP regimen combined with CT maintained cognitive and behavioral stability in AD patients for at least 12 months, with cognitive enhancement and behavioral synergy after 9 months, and cognitive benefit was superior to CT at 9, 12, 15, 18, 21, and 24 months, respectively. The 2-year cognitive improvement rate was increased by 25.64% (P=0.020) and the cognitive deterioration rate was decreased by 48.71% (P=0.000). Among them, the cognitive and functional benefits of Shen-reinforcing therapy for very early AD (350 cases) for 1 year were better than the placebo (P<0.001), and the dementia conversion rate was reduced by 8.85% (P=0.002). The behavioral symptomatic relief of patients with vascular dementia received fire-purging therapy (540 cases) was superior to those received CT (P=0.016). These data suggested that the STEP regimen has synergistic effects on CTs at least in terms of cognitive benefit, and the earlier the use, the greater the benefit will have. Therefore, the STEP regimen should be considered as one of the clinical options, particularly for the dearth of effective pharmaceutical or immunological interventions that are currently available for AD. 相似文献
100.
The objective of this study was to investigate the absorption behavior of chikusetsusaponin IVa (CHS‐IVa) in the rat intestine using single‐pass intestinal perfusion (SPIP) and to classify CHS‐IVa into the biopharmaceutics classification system (BCS). The equilibrium solubility of CHS‐IVa was determined by the shaker method. The absorption mechanism of CHS‐IVa in the intestine was studied by comparing the Peff of different concentrations of CHS‐IVa. The intestinal site dependence of CHS‐IVa absorption was studied by comparing the Peff of the same concentration of CHS‐IVa in different intestinal segments. The relationship between CHS‐IVa and intestinal efflux protein was studied by perfusion with an efflux protein inhibitor. The permeability of CHS‐IVa was investigated by comparing the Peff of CHS‐IVa and the reported value. The solubility of CHS‐IVa over the pH range 1.0–7.5 was 14.4 ± 0.29 to 16.9 ± 0.34 mg/ml. The Peff of CHS‐IVa in the duodenum was 1.76 × 10?3 to 2.00 × 10?3 cm/min. The Peff of CHS‐IVa in the jejunum was 1.26 × 10?3 to 1.39 × 10?3 cm/min. The Peff of CHS‐IVa in the ileum was 1.25 × 10?3 to 1.31 × 10?3 cm/min. The Peff of CHS‐IVa in the colon was 1.02 × 10?3 to 1.08 × 10?3 cm/min. There was no statistical difference of the Peff in the four segments at different CHS‐IVa concentrations. The Peff of CHS‐IVa (0.07, 0.7 and 7.0 mg/ml) were all notably smaller than the reported Peff (3.00 × 10?3 cm/min) in the jejunum. The Peff of CHS‐IVa was not influenced by verapamil (P‐gp inhibitor), indomethacin (MRP inhibitor) and pantoprazole (BCRP inhibitor). CHS‐IVa was classified as high solubility, low permeability and BCS III. The main absorptive tracts were the upper intestinal tracts and the rank order of intestinal permeability was duodenum > jejunum ≈ ileum > colon. The transport mechanism of CHS‐IVa in all intestinal segments might be primarily passive transport. CHS‐IVa was not a substrate of P‐gp, MRP and BCRP. 相似文献